Crop Life Science Limited (CLSL)
Latest quarterly results (H2 FY26)
In its latest reported quarter, H2 FY26, Crop Life's revenue was ₹87.0 Cr (-7.4% year on year, -27.5% on the previous half-year), and net profit ₹4.0 Cr (+33.3% year on year); the operating margin was 10.3%.
| H2 FY26 (₹ Cr) | Value | YoY vs H2 FY25 | vs prev. half |
|---|---|---|---|
| Revenue | ₹87.0 | -7.4% | -27.5% |
| Operating profit | ₹9.0 | +12.5% | +12.5% |
| Net profit | ₹4.0 | +33.3% | +33.3% |
| EPS (₹) | 2.19 | +17.7% | +16.5% |
| Operating margin | 10.3% | — | — |
📢 Recent Corporate Announcements
Crop Life Science Limited announced the deferral of its proposed wholly owned subsidiary in Sharjah, UAE, stating the matter will be reconsidered later. Simultaneously, the board noted the resignation of two Independent Directors, Mr. Harendra Mukeshbhai Sevak and Mr. Devang Bhikhubhai Parekh, effective October 10, 2026. Consequent to these departures, the company has reconstituted its Audit, Stakeholders Relationship, Nomination & Remuneration, and CSR committees.
- Board decided to further defer the incorporation of a wholly owned subsidiary in Sharjah, UAE
- Resignation of 2 Independent Directors: Mr. Harendra Mukeshbhai Sevak and Mr. Devang Bhikhubhai Parekh
- Reconstitution of 4 Board committees (Audit, Stakeholders, NRC, CSR) effective October 10, 2026
- Board meeting held on October 10, 2026, lasting 45 minutes (02:00 PM to 02:45 PM)
Crop Life Science Limited has submitted its quarterly compliance certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026. The certificate issued by Registrar and Share Transfer Agent Purva Sharegistry (India) Private Limited confirms that dematerialisation requests received during the period were processed and verified within stipulated timelines. The filing is an administrative regulatory requirement with zero financial or operational impact.
- Compliance certificate submitted under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018
- Covers the quarter ended September 30, 2026
- Confirmation issued by RTA Purva Sharegistry (India) Private Limited on October 01, 2026
- Company filing completed on October 02, 2026
Crop Life Science Limited announced the voting results of its 20th Annual General Meeting held on September 23, 2026. All six resolutions were approved by shareholders with over 99.8% majority, including the adoption of FY26 financials and appointments of independent directors. Notably, Resolution 6 approving a material related party transaction with Hetban Spechem Limited was passed with 99.84% approval (12,54,000 votes in favor). Overall voting participation stood at 77.34% of total outstanding shares.
- All 6 resolutions passed at the 20th AGM with over 99.8% approval
- Overall voter turnout was 77.34% (1,32,56,000 votes polled out of 1,71,40,000 shares)
- Promoter turnout stood at 100% of their 1,15,20,000 shares, voting entirely in favor
- Material Related Party Transaction with Hetban Spechem Limited approved with 99.84% votes in favor (12,54,000 shares)
- Appointment of two Non-Executive Independent Directors approved by special resolutions
Crop Life Science Limited has issued notice regarding its 20th Annual General Meeting (AGM) scheduled for Wednesday, September 23, 2026, at 03:30 PM IST via Video Conferencing/OAVM. Pursuant to SEBI Regulation 36(1)(b), the company has dispatched letters containing the Annual Report FY 2025-26 web-link to shareholders without registered email addresses as of the cut-off date August 21, 2026. The communication also includes standard reminders for physical shareholders to update mandatory KYC details.
- 20th Annual General Meeting scheduled for Wednesday, 23rd September, 2026, at 03:30 P.M. IST
- Meeting to be conducted virtually through Video Conferencing (VC) / Other Audio Visual Means (OAVM)
- Cut-off date for dispatch of physical communication to non-email registered shareholders was Friday, 21st August, 2026
- Annual Report FY2025-26 hosted on the company website pursuant to SEBI Regulation 36(1)(b)
Crop Life Science Limited has issued the notice for its 20th Annual General Meeting scheduled for September 23, 2026. Key agenda items include adopting FY26 financial statements and appointing two Non-Executive Independent Directors for a five-year term ending July 2031. Additionally, the company seeks shareholder approval for material related party transactions up to ₹125 Crores with its subsidiary, Hetban Spechem Limited, which represents ~30.7% of CLSL's TTM revenue of ₹407 Crores.
- 20th AGM scheduled for September 23, 2026, at 03:30 PM IST via Video Conferencing
- Proposed approval for material Related Party Transactions with subsidiary Hetban Spechem Ltd up to ₹125 Crores
- Appointment of Alpeshbhai G. Vaghasiya and Pareshbhai B. Parsana as Independent Directors for 5-year terms up to July 29, 2031
- Cost audit fees ratified at ₹1,10,000 plus applicable taxes for FY 2026-27
Crop Life Science Limited announced that its 20th Annual General Meeting (AGM) will be held on September 23, 2026, at 03:30 PM IST via video conferencing. The Board approved the annual Directors' Report for the financial year ended March 31, 2026, and appointed a scrutinizer for remote e-voting. Additionally, the Board evaluated a proposal to incorporate a wholly-owned overseas subsidiary and invest in it, but decided to defer the decision for further evaluation.
- 20th Annual General Meeting scheduled for September 23, 2026 at 03:30 P.M. IST via VC/OAVM
- Board approved the Directors' Report and annexures for the financial year ended March 31, 2026
- Proposal to incorporate and invest in an overseas wholly-owned subsidiary was deferred for further evaluation
- Appointed Mr. Ranjit Kumar Singh, Practicing Company Secretary, as e-voting scrutinizer
Crop Life Science Limited (CLSL) has appointed Mr. Alpeshbhai Gordhanbhai Vaghasiya as an Additional (Independent) Director effective July 30, 2026. The appointment is for a fixed term of 5 years, pending shareholder regularization. Mr. Vaghasiya, aged 37, joins the board of this Rs 110 Cr market cap agrochemical company to provide strategic oversight. This is a routine governance update and does not impact the company's immediate financial operations.
- Appointment of Mr. Alpeshbhai Gordhanbhai Vaghasiya as Additional (Independent) Director effective July 30, 2026
- The tenure for the new Independent Director is set for a period of 5 years
- The appointee is 37 years old with expertise in management and leadership skills
- CLSL reported TTM revenue of Rs 407 Cr and a PAT of Rs 13 Cr as of the latest filings
- Promoter holding remains stable at 70.01% as of March 2026
Crop Life Science Limited (CLSL) has appointed Mr. Alpeshbhai Gordhanbhai Vaghasiya as an Additional (Independent) Director effective July 30, 2026. The appointment is for a five-year term, subject to regularization by shareholders. Mr. Vaghasiya, aged 37, is expected to contribute strategic insight and independent judgment to the board. This is a routine governance update for the company, which currently has a market capitalization of Rs 110 crore and TTM revenue of Rs 407 crore.
- Appointment of Mr. Alpeshbhai Gordhanbhai Vaghasiya as Additional (Independent) Director effective July 30, 2026.
- The tenure for the appointment is fixed for a period of 5 years.
- The appointee is 37 years old with expertise in management and leadership skills.
- The company reported TTM revenue of Rs 407 crore and an OPM of 8.4% in the latest financial context.
Crop Life Science Limited (CLSL) has appointed Mr. Alpeshbhai Gordhanbhai Vaghasiya as an Additional (Independent) Director for a five-year term starting July 30, 2026. The appointment is subject to regularization by shareholders in the next general meeting. Mr. Vaghasiya, aged 37, is expected to provide strategic insight and independent judgment to the board. This is a routine governance update for the company, which has a market capitalization of Rs 110 Cr and TTM revenue of Rs 407 Cr.
- Appointment of Mr. Alpeshbhai Gordhanbhai Vaghasiya as Additional (Independent) Director effective July 30, 2026.
- The tenure for the appointment is fixed for a period of 5 years.
- The appointee is 37 years old with expertise in management and operational efficiency.
- The appointment is subject to shareholder approval as per SEBI (LODR) Regulations.
Crop Life Science Limited (CLSL) has appointed Mr. Alpeshbhai Gordhanbhai Vaghasiya as an Additional (Independent) Director effective July 30, 2026. The appointment is for a five-year term, subject to regularization by shareholders. Mr. Vaghasiya, aged 37, is cited to have expertise in management and operational efficiency. This appointment is part of the company's routine board governance for its Rs 110 Cr market cap business.
- Appointment of Mr. Alpeshbhai Gordhanbhai Vaghasiya as Additional (Independent) Director effective July 30, 2026
- The appointment is for a fixed tenure of 5 years, pending shareholder approval
- The new director is 37 years old and brings expertise in business growth and operational efficiency
- The company maintains a high promoter holding of 70.01% as of March 2026
Crop Life Science Limited (CLSL) has appointed two new Independent Directors, Mr. Pareshbhai Bhagvanbhai Parsana and Mr. Alpeshbhai Gordhanbhai Vaghasiya, for five-year terms effective July 30, 2026. The board also finalized the appointment of M/s. Y. S. Thakar & Co. as Cost Auditors and M/s A R Shaikh & Co as Internal Auditors for the financial year 2026-27. These appointments are routine governance measures for the company, which currently holds a market capitalization of Rs 110 Cr and TTM revenue of Rs 407 Cr. The director appointments remain subject to shareholder approval.
- Appointment of 2 Independent Directors for a 5-year consecutive term starting July 30, 2026.
- M/s. Y. S. Thakar & Co. appointed as Cost Auditor for the Financial Year 2026-27.
- M/s A R Shaikh & Co appointed as Internal Auditor for the Financial Year 2026-27.
- Board meeting conducted and concluded within 50 minutes (16:00 to 16:50 IST).
Financial Performance
Revenue Growth by Segment
Agro Chemicals remains the primary driver with revenue of INR 11,926.50 Lacs in H1 FY26 compared to INR 20,059.00 Lacs for the full year FY25. Agro Trade revenue reached INR 100.75 Lacs in H1 FY26, nearly matching its total FY25 revenue of INR 101.73 Lacs, indicating a significant acceleration in trading activities.
Geographic Revenue Split
Not disclosed in available documents, though the company emphasizes 'Huge Export Potential' and plans for 'Increase in Geographical Presence'.
Profitability Margins
The Consolidated Net Profit Ratio was 2.79% for FY25, a decrease of 7.81% YoY from 3.03% in FY24. Standalone Net Profit Ratio for FY25 was 3.30%, up 8.48% YoY.
EBITDA Margin
Consolidated EBITDA for FY25 was INR 17.38 Cr (INR 1,737.52 Lacs), representing an EBITDA margin of approximately 8.66% based on FY25 revenue of INR 20,059.00 Lacs.
Capital Expenditure
Historical capital expenditure for H1 FY26 included INR 4.38 Cr (INR 437.74 Lacs) for the purchase of Property, Plant, and Equipment. Planned expenditure is focused on increasing geographical presence and product portfolio expansion.
Credit Rating & Borrowing
The Debt-Equity Ratio stood at 0.52 for FY25, an increase of 20.19% YoY from 0.44 in FY24, driven by additional borrowings from financial institutions to fund operations. Finance costs for H1 FY26 were INR 2.82 Cr (INR 282.27 Lacs).
Operational Drivers
Raw Materials
Technical formulations and active ingredients for Pesticides, Insecticides, Herbicides, and Fertilizers represent the core raw material requirements, accounting for approximately 83.3% of revenue (INR 10,020.93 Lacs in H1 FY26).
Import Sources
Not specifically disclosed, but the company notes a requirement for foreign government approvals for exports, suggesting international supply chain linkages.
Capacity Expansion
Current installed capacity is not specified in MT; however, the company is actively expanding its product portfolio and geographical footprint to utilize its works at Ankleshwar, Gujarat.
Raw Material Costs
Cost of materials consumed was INR 10,020.93 Lacs in H1 FY26, representing 83.3% of revenue from operations. This high percentage makes the company sensitive to price fluctuations in chemical technicals.
Logistics & Distribution
The company utilizes an extensive marketing setup including dealer training programs, field demonstrations, and farmer training to manage distribution across target regions.
Strategic Growth
Growth Strategy
Growth will be driven by increasing geographical presence, expanding the product portfolio (Antibiotics, Bactericides, etc.), and strengthening the brand through extensive marketing activities such as field shows and dealer training. The company is also leveraging its subsidiary, Hetban Spec-Chem Limited, for broader market reach.
Products & Services
The company sells Antibiotics, Bactericides, Plant Growth Regulators, Micro Fertilizers, Pesticides, Insecticides, Fungicides, and Weedicides.
Brand Portfolio
Crop Life Science Limited (CLSL).
New Products/Services
The company is focused on 'Increasing our product Portfolio' particularly in the R&D of new agrochemical technicals and formulations.
Market Expansion
Targeting both domestic expansion and international markets through 'Huge Export Potential' and seeking foreign government approvals.
Strategic Alliances
The company operates with a subsidiary, Hetban Spec-Chem Limited, which is included in its consolidated financial results.
External Factors
Industry Trends
The industry is shifting toward Integrated Pest Management (IPM) and organic farming. There is a rising global demand for food grains, which supports a growing market for yield-enhancing agrochemicals.
Competitive Landscape
The company operates in a competitive SME segment of the agrochemical industry, facing risks from industry cycles and economic headwinds.
Competitive Moat
The company's moat is built on its brand image, extensive marketing setup, and a diversified product portfolio across multiple agrochemical verticals. These are sustainable through continuous dealer engagement and R&D.
Macro Economic Sensitivity
Highly sensitive to agricultural output and rainfall; growth in food grain demand and organic farming trends (IPM) are key macro drivers.
Consumer Behavior
Farmers are increasingly adopting organic farming and IPM, requiring the company to adapt its product mix toward more sustainable formulations.
Geopolitical Risks
Export operations are subject to foreign government approvals and changing international regulatory norms.
Regulatory & Governance
Industry Regulations
Operations are governed by the Companies Act 2013, SEBI (LODR) Regulations 2015, and specific agrochemical regulatory norms including foreign government export approvals.
Environmental Compliance
The company is aligning with Integrated Pest Management (IPM) and organic farming trends, though specific ESG compliance costs are not disclosed.
Taxation Policy Impact
The effective tax rate for H1 FY26 was approximately 26.34% based on standalone profit before tax of INR 437.74 Lacs and tax expense of INR 115.31 Lacs.
Legal Contingencies
The company reported an exceptional gain of INR 29.63 Lacs in H1 FY26 related to the cancellation of a lease and transfer of land liability.
Risk Analysis
Key Uncertainties
High dependence on natural climate and rainfall (potential 20%+ impact on seasonal revenue) and frequently changing government regulatory norms.
Geographic Concentration Risk
Manufacturing operations are concentrated in Ankleshwar, Gujarat, making it sensitive to regional industrial policies.
Third Party Dependencies
Significant reliance on a network of dealers and distribution partners for reaching individual farmers.
Technology Obsolescence Risk
Risk of traditional pesticides being replaced by bio-pesticides or organic alternatives if R&D does not keep pace.
Credit & Counterparty Risk
Trade Receivables Turnover Ratio decreased to 2.74 in FY25 (down 24.32% YoY), indicating a potential increase in credit risk or longer collection cycles from distributors.
